Search

everythinglearnresearchcommunity

for

Search:↓

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Certain skin symptoms can help detect and manage systemic lupus.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Vitamin D is crucial for skin health and managing skin diseases.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Certain diseases like AIDS and lupus can make African hair become silky.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Effective treatments for severe alopecia areata are still lacking.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.